Immunotech Laboratories, Inc. signed a contract with partner in Bulgaria to register a company called Immunotech Laboratories B.G. LLC

Immunotech Laboratories, Inc. (IMMB) signed a contract with strategic partners in Bulgaria to register a company called Immunotech Laboratories B.G. LLC. Immunotech Laboratories, Inc. will own 49% of the Bulgarian subsidiary. The goal of Immunotech Laboratories BG is to conduct pre-clinical testing, clinical trials phase I, phase II, and phase III to reach registration of the product based on IPF platform called ImmuneH for treatment of HIV/AIDS and Hepatitis C. Furthermore Immunotech Laboratories B.G. will obtain rights for the eventual production in Bulgaria.